Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России, Кемерово, Россия
Список исп. литературыСкрыть список 1. Deter HC, Orth-Gomér K, Wasilewski B, Verissimo R. The European Network on Psychosomatic Medicine (ENPM) – history and future directions. BioPsychoSocial Medicine 2017; 11 (1). DOI: 10.1186/s13030-016-0086-0 2. Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiplogy, Clinical Features, and Rome IV Gastroenterology. Gastroenterology 2016; Feb 19: S0016-5085(16)00223-7. DOI: 10.1053/j.gastro.2016.02.032 3. Williams RB. Psychosocial and biobehavioral factors and their interplay in coronary heart disease. Ann Rev Clin Psychol 2008; 4 (1): 349–65. DOI: 10.1146/annurev.clinpsy.4.022007.141237 4. Chisholm D, Sweeny K, Sheehan P et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry 2016; 3 (5): 415–24. DOI: 10.1016/S2215-0366(16)30024-4 5. Keefer L. Behavioural medicine and gastrointestinal disorders: the promise of positive psychology. Nature Reviews. Gastroenterol Hepatol 2018; 15 (6): 378–86. DOI: 10.1038/s41575-018-0001-1 6. Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease. Gastroenterol 2018; 154 (6): 1635–46.e3. DOI: 10.1053/j.gastro.2018.01.027 7. Henningsen P, Zipfel S, Sattel H, Creed F. Management of functional somatic syndromes and bodily distress. Psychotherapy Psychosomatics 2018; 87 (1): 12–31. DOI: 10.1159/000484413 8. Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychotherapy Psychosomatics 2016; 86 (1): 13–30. DOI: 10.1159/ 000448856 9. Wang F, Wang L, Wang Y et al. Exogenous IGF-1 improves cognitive function in rats with high-fat diet consumption. J Molecular Endocrinology 2020; 64 (2): 115–23. DOI: 10.1530/JME-19-0150 10. Cepoiu M, McCusker J, Cole MG et al. Recognition of depression by non-psychiatric physicians – a systematic literature review and meta-analysis. J General Internal Med 2008; 23 (1): 25–36. DOI: 10.1007/s11606-007-0428-5 11. Kroenke K, Spitzer RL, Williams JBW et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Int Med 2007; 146 (5): 317–25. DOI: 10.7326/0003-4819-146-5-200703060-00004 12. Kindt S, Van Oudenhove L, Mispelon L et al. Longitudinal and cross-sectional factors associated with long-term clinical course in functional dyspepsia: a 5-year follow-up study. Am J Gastroenterol 2011; 106 (2): 340–8. DOI: 10.1038/ajg.2010.406 13. Mykletun A, Jacka F, Williams L et al. Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterology 2010; 10 (1). DOI: 10.1186/1471-230x-10-88 14. Mapel DW. Functional disorders of the gastrointestinal tract: cost effectiveness review. Best Pract Rese Clin Gastroenterol 2013; 27: 913–31. DOI: 10.1016/j.bpg.2013.09.003 15. Chandran S, Prakrithi SN, Mathur S et al. A review of functional gastrointestinal disorders: A primer for mental health professionals. Arch Mental Health 2018; 19: 70. DOI: 10.4103/AMH.AMH_25_18 16. Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastroenterol Hepatol 2005; 20: 332–9. DOI: 10.1111/j.1440-1746.2004. 03508.x 17. Sakall A. Psychiatric factors and psychosomatic symptoms in functional gastrointestinal disorders. Klinik Psik of arma koloji Bulteni 2019; 29: 427 18. Jones MP, Tack J, Van Oudenhove L, Walker MM, Holtmann G, Koloski NA et al. Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population. Clin Gastroenterol Hepatol 2017; 15: 1014–20. DOI: 10.1016/j.cgh.2016.12.032 19. Chandran S, Prakrithi SN, Mathur S et al. A review of functional gastrointestinal disorders: A primer for mental health professionals. Arch Mental Health 2018; 19: 70. DOI: 10.4103/AMH.AMH_25_18 20. Afari N, Ahumada SM, Wright LJ et al. Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosomatic Med 2014; 76: 2–11. DOI: 10.1097/PSY. 0000000000000010 21. Lee SP, Sung IK, Kim JH et al. The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motility 2015; 21: 273–82. DOI: 10.5056/jnm14116 22. Hertig VL, Cain KC, Jarrett ME et al. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs Res 2007; 56: 399–406. DOI: 10.1097/01.NNR.0000299855.60053.88 23. North CS, Hong BA, Alpers DH. Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol 2007; 13: 2020. DOI: 10.3748/wjg.v13.i14.2020 24. Mertz H. Stress and the Gut. UNC School of Medicine. Chapel Hill, NC: www. MED. UNC. EDU/IBS. 2011 Mar. 25. Mearin F, Malfertheiner P. Functional gastrointestinal disorders: complex treatments for complex pathophysiological mechanisms. Dig Dis 2017; 35: 1–4. DOI: 10.1159/000485407 26. Van Oudenhove L, Vandenberghe J, Demyttenaere K, Tack J. Psychosocial factors, psychiatric illness and functional gastrointestinal disorders: a historical perspective. Digestion 2010; 82 (4): 201–10. DOI: 10.1159/000269822 27. Feng L, Li Z, Gu X et al. Psychosomatic Disorders in Patients with Gastrointestinal Diseases: Single-Center Cross-Sectional Study of 1186 Inpatients. Gastroenterol Res Pract 2021; 2021: 6637084. DOI: 10.1155/2021/6637084 28. Pinto-Sanchez MI, Ford AC, Avila CA et al. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015; 110 (7): 1038–48. DOI: 10.1038/ajg.2015.128 29. Rice SM, Gwyther K, Santesteban-Echarri O et al. Determinants of anxiety in elite athletes: a systematic review and meta-analysis. British J Sports Med 2019; 53(11): 722–30. DOI: 10.1136/bjsports-2019-100620 30. Ray LB. Explaining gender differences in anxiety. Science 2016; 354 (6310): 298–9. DOI: 10.1126/science.354.6310.298-g 31. Nolen-Hoeksema S. Emotion regulation and psychopathology: the role of gender. Ann Rev Clin Psychol 2012; 8 (1): 161–87. DOI: 10.1146/annurev-clinpsy-032511-143109 32. Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry 2017; 4 (1): 73–82. DOI: 10.1016/S2215-0366(16)30358-3 33. Li K, Nakajima M, Ibañez-Tallon I, Heintz N. A cortical circuit for sexually dimorphic oxytocin-dependent anxiety behaviors. Cell 2016; 167 (1): 60–72.e11. DOI: 10.1016/j.cell.2016.08.067 34. Mei L, Xiao ZP, He YL, Fan Q. Survey on the prevalence of anxiety disorders in internal medical outpatients at general hospital. Zhonghua Yi Xue Za Zhi 2010; 90 (45): 3172–5. 35. Chu C, Murdock MH, Jing D et al. The microbiota regulate neuronal function and fear extinction learning. Nature 2019; 574 (7779): 543–548. DOI: 10.1038/s41586-019-1644-y 36. Cryan JF, O'Riordan KJ, Cowan CSM et al. The microbiota-gut-brain axis. Physiological Reviews 2019; 99 (4): 1877–2013. DOI: 10.1152/physrev.00018.2018 37. Zhang JJ, Ma H, Zhu JZ et al. The Role of Dietary Energy and Macronutrients Intake in Prevalence of Irritable Bowel Syndromes. Biomed Res Int 2019; 2019: 8967306. DOI: 10.1155/2019/8967306 38. Faresjö Å, Walter S, Norlin AK et al. Gastrointestinal Symptoms – An Illness Burden That Affects Daily Work in Patients with IBS. Health Qual Life Outcomes 2019; 17: 1–7. DOI: 10.1186/s12955-019-1174-1 39. Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, Dumitrascu DL. The Relationship between Irritable Bowel Syndrome and Psychiatric Disorders: From Molecular Changes to Clinical Manifestations. J Mol Psychiatry 2014; 2: 4. DOI: 10.1186/2049-9256-2-4 40. Faresjö Å, Grodzinsky E, Hallert C, Timpka T. Patients with Irritable Bowel Syndrome Are More Burdened by Co-Morbidity and Worry about Serious Diseases than Healthy Controls- Eight Years Follow-up of IBS Patients in Primary Care. BMC Public Health 2013; 13: 1–8. DOI: 10.1186/1471-2458-13-832 41. Tofighi B. A Study of the Relationship between Stress and Psychosomatic Disorders. Int Proc Econom Develop Res 2012; 44: 124–7. 42. Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut 2000; 47: 861–9. DOI: 10.1136/gut.47.6.861 43. Blanchard EB, Lackner JM, Jaccard J et al. The role of stress in symptom exacerbation among IBS patients. J Psychosom Res 2008; 64: 119–28. DOI: 10.1016/j.jpsychores.2007.10.010 44. Lee EY, Mun MS, Lee SH, Cho HS. Perceived stress and gastrointestinal symptoms in nursing students in Korea: A cross-sectional survey. BMC Nurs 2011; 10: 22. DOI: 10.1186/1472-6955-10-22 45. Moloney RD, Johnson AC, O’Mahony SM et al. Stress and the Microbiota-Gut-Brain Axis in Visceral PaRelevance to Irritable Bowel Syndrome. CNS Neurosci. Ther 2016; 22: 102–17. DOI: 10.1111/cns.12490 46. Pellissier S, Dantzer C, Mondillon L, Trocme C et al. Relationship between Vagal Tone, Cortisol, TNF-Alpha, Epinephrine and Negative Affects in Crohn’s Disease and Irritable Bowel Syndrome. PLoS ONE 2014; 9:e105328. DOI: 10.1371/journal.pone.0105328 47. Bonaz B, Sinniger V, Pellissier S. The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol 2017; 8: 1452. DOI: 10.3389/fimmu.2017.01452 48. Bonaz B, Bazin T, Pellissier S. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front. Neurosci 2018; 12: 49. DOI: 10.3389/fnins.2018.00049 49. Van Thiel IAM, de Jonge WJ, Chiu IM, van den Wijngaard RM. Microbiota-Neuroimmune Cross Talk in Stress-Induced Visceral Hypersensitivity of the Bowel. Am J Physiol Gastrointest Liver Physiol 2020; 318: G1034–G1041. DOI: 10.1152/ajpgi.00196.2019 50. Elsenbruch S. Abdominal Pain in Irritable Bowel Syndrome: A Review of Putative Psychological, Neural and Neuro-Immune Mechanisms. Brain Behav Immun 2011; 25: 386–94. DOI: 10.1016/j.bbi. 2010.11.010 51. Steinsvik EK, Valeur J, Hausken T, Gilja OH. Postprandial symptoms in patients with functional dyspepsia and irritable bowel syndrome: relations to ultrasound measurements and psychological factors. J Neurogastroenterology Motility 2020; 26 (1): 96–105. DOI: 10.5056/jnm19072 52. Frandemark A, Tornblom H, Jakobsson S et al. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. Am J Gastroenterol 2018; 113 (10): 1540–9. DOI: 10.1038/s41395-018-0262-x 53. Frolkis AD, Vallerand IA, Shaheen AA et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut 2019; 68 (9): 1606–12. DOI: 10.1136/gutjnl-2018-317182 54. Simrén M, Törnblom H, Palsson OS et al. Cumulative effects of psychologic distress, visceral hypersensitivity, and abnormal transit on patient-reported outcomes in irritable bowel syndrome. Gastroenterology 2019; 157 (2): 391–402.e2. DOI: 10.1053/j.gastro.2019. 04.019 55. Van Oudenhove L, Levy RL, Crowell MD et al. Biopsychosocial Aspects of Functional Gastrointestinal Disorders: How Central and Environmental Processes Contribute to the Development and Expression of Functional Gastrointestinal Disorders. Gastroenterol 2016; 150 (6): 1355–67.e2. DOI: 10.1053/j.gastro.2016.02.027 56. Feng L, Li Z, Gu X et al. Psychosomatic Disorders in Patients with Gastrointestinal Diseases: Single-Center Cross-Sectional Study of 1186 Inpatients. Gastroenterol Res Pract 2021; 2021: 6637084. DOI: 10.1155/2021/6637084 57. Levecque K, Lodewyckx I, Vranken J. Depression and generalised anxiety in the general population in Belgium: a comparison between native and immigrant groups. J Affective Disorders 2007; 97 (1–3): 229–39. DOI: 10.1016/j.jad.2006.06.022 58. Meissel EEE, Salthouse TA. Relations of naturally occurring variations in state anxiety and cognitive functioning. Personality Individual Differences 2016; 98: 85–90. DOI: 10.1016/j.paid.2016.04.018 59. Arean P, Hegel M, Vannoy S et al. Effectiveness of problem-solving therapy for older, primary care patients with depression: results from the IMPACT project. Gerontologist 2008; 48 (3): 311–23. DOI: 10.1093/geront/48.3.311 60. Shiha MG, Asghar Z, Thoufeeq Mo, Kurien M et al. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria. Neurogastroenterol Motil 2021; 33 (10): e14121. DOI: 10.1111/nmo.14121 61. Fink P, Schröder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 2010; 68: 415–26. DOI: 10.1016/j.jpsychores.2010.02.004 62. McGloin JM, Widom CS. Resilience among abused and neglected children grown up. Dev Psychopathol 2001; 13: 1021–38. DOI: 10.1017/S095457940100414X 63. Penza KM, Heim C, Nemeroff CB. Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety. Arch Womens Ment Health 2003; 6: 15–22. DOI: 10.1007/ s00737-002-0159-x 64. Bragee B, Bullington J. From health to disease: a new approach to study the emergence of psychosomatic symptoms. Psychother Psychosom 2003; 72: 228–9. DOI: 10.1159/000070788 65. Phillips K, Wright BJ, Kent S. Psychosocial predictors of irritable bowel syndrome diagnosis and symptom severity. J Psychosom Res 2013; 75: 467–74. DOI: 10.1016/j.jpsychores.2013.08.002 66. Bucci W. The role of subjectivity and intersubjectivity in the reconstruction of dissociated schemas; converging perspectives from psychoanalysis, cognitive science and affective neuroscience. Psychoanalytic Psychology 2011; 28: 247–66. DOI: 10.1037/a0023170 67. Waller G, Hamilton K, Elliot P et al. Somatoform dissociation, psychological dissociation, and specific forms of trauma. J Trauma and Dissociation 2001; 1: 81–98. DOI: 10.1300/J229v01n04_05 68. Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil 2011; 17: 131–9. DOI: 10.5056/jnm.2011.17.2.131 69. Coss-Adame E, Rao SS. Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings. Curr Gastroenterol Rep 2014; 16: 379. DOI: 10.1007/s11894-014-0379-z 70. Chogle A, Mintjens S, Saps M. Pediatric IBS: an overview on pathophysiology, diagnosis and treatment. Pediatr Ann 2014; 43: e76–e82. DOI: 10.3928/00904481-20140325-08 71. Landsman-Dijkstra JJ, van Wijck R, Groothoff JW. The long-term lasting effectiveness on self-efficacy, attribution style, expression of emotions and quality of life of a body awareness program for chronic a-specific psychosomatic symptoms. Patient Educ Couns 2006; 60: 66–79. DOI: 10.1016/j.pec.2004.12.003 72. Gyllensten AL, Skär L, Miller M, Gard G. Embodied identity--a deeper understanding of body awareness. Physiother Theory Pract 2010; 26: 439–46. DOI: 10.3109/09593980903422956 73. Mearin F. Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders. Digestion 2006; 73 (Suppl. 1): 28–37. DOI: 10.1159/000089777 74. Camilleri M. Irritable Bowel Syndrome: Straightening the road from the Rome criteria. Neurogastroenterol Motil 2020; 32 (11): e13957. DOI: 10.1111/nmo.13957 75. Palsson OS, Drossman DA. Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments. Gastroenterol Clin North Am 2005; 34: 281–303. DOI: 10.1016/ j.gtc.2005.02.004 76. Lackner JM, Mesmer C, Morley S et al. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol 2004; 72: 1100–13. DOI: 10.1037/0022-006X.72.6.1100 77. Siah KTH, Gong X, Yang XJ et al. Rome Foundation-Asian working team report: Asian functional gastrointestinal disorder symptom clusters. Gut 2018; 67: 1071–7. DOI: 10.1136/gutjnl-2016-312852 78. Holtmann GJ, Talley NJ. Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning? Gut 2018; 67: 1911–5. DOI: 10.1136/gutjnl-2017-314775 79. Nozari N. COVID-19 Outbreak and its Burden on a New Wave of Functional Gastrointestinal Disorders. Middle East J Dig Dis 2021; 13 (2): 91–4. DOI: 10.34172/mejdd.2021.210 80. Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol 2019; 25: 1185–96. DOI: 10.3748/wjg.v25.i10.1185 81. Camilleri M. Neurogastroenterology and Motility What’s in the pipeline for lower functional gastrointestinal disorders in the next 5 years? Am J Physiol Gastrointest Liver Physiol 2019; 317 (5): G640–G650. DOI: 10.1152/ajpgi.00205.2019 82. Mohan LJ, Daly JS, Ryan BM, Ramtoola Z. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scand J Gastroenterol 54: 18–26, 2019. DOI: 10.1080/00365521.2018.1563805